Submissions - Specialised Therapeutics

ST has made several key recommendations to the Federal Government’s National Medicines Policy Review, to improve timely and affordable access to specialist medicines. Click to read full submission.

Specialised Therapeutics Australia (STA) welcomes the opportunity to provide comments on the introduction of new measures to improve TGA transparency. STA was co-founded in 2008, with a commitment to commercialising specialist therapies and technologies that meet the unmet medical needs of all patients in its regions. Underpinning this endeavour is a foundation of innovation, which must be protected by regulatory transparency.

By Carlo Montagner, CEO Specialised Therapeutics Australia Dear PBS Improvements Section, My name is Carlo Montagner and I am the Chief Executive Officer and co-founder of Australia’s largest independent pharmaceutical company, Specialised Therapeutics Australia (STA). We are a wholly family-owned Australian company, supplying specialist therapies and technologies to patients throughout Australia, as well as in